71
Participants
Start Date
February 28, 2015
Primary Completion Date
May 2, 2016
Study Completion Date
May 2, 2016
dimethyl fumarate
Throughout the study participants will remain on their existing, stable dosing regimen of Tecfidera.
tetanus diphtheria toxoids vaccine
Administered as described in the treatment arm
23-valent pneumococcal polysaccharide vaccine
Administered as described in the treatment arm
meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)
Administered as described in the treatment arm
non-pegylated interferon
Throughout the study participants will remain on their existing, stable dosing regimen of non-pegylated IFN.
Research Site, New York
Research Site, Charlotte
Research Site, Fort Lauderdale
Research Site, Sarasota
Research Site, Lexington
Research Site, Cleveland
Research Site, Akron
Research Site, Dayton
Research Site, Indianapolis
Research Site, San Antonio
Research Site, Round Rock
Research Site, Thornton
Research Site, Gilbert
Research Site, Auburn
Lead Sponsor
Biogen
INDUSTRY